Project Details
Description
Spreading Depolarization (SD) is associated with migraine aura and is recognized as a novel mechanism of
injury in stroke and brain trauma patients. SDs are waves of sustained depolarization of neurons and glia that
propagate the breakdown of transmembrane ion gradients, distortion of synaptic circuitry, and cytotoxic edema.
Yet, the fundamental question of the molecular mechanism of rapid water entry into depolarized neurons remains
an enigma. Passive osmotically obligated water flux following cations influx during SD is problematic because
pyramidal neurons are highly resilient to osmotic swelling due to a lack of aquaporins in their membrane. Based
on our preliminary data and the literature, it is plausible that volume-regulated Cl-/anion channels (VRAC) are
involved in SD-induced neuronal swelling and recovery. In neurons lacking aquaporins, VRAC may either
promote neuronal swelling during strong depolarization as a route for swelling-aggravating Cl- influx or assist in
neuronal volume recovery during repolarization, providing a conduit for Cl- efflux. Thus, by serving as a major
anionic pathway, VRAC plays a dual reciprocal role in neuronal volume regulation, and it conducts water. Aim 1
will reveal the role of VRAC in SD-induced neuronal edema and recovery. SD could lead to cell death in the
energy-deprived cortex, but not all neurons die. Little is known about the cause of this variability across
depolarized but viable neurons. It is feasible that the variation in the increased levels and duration of
mitochondrial Ca2+ during SD could underlie this variability. However, in vivo mitochondrial Ca2+ levels in SD
were never quantified, and cells were never followed in real-time until their death or recovery. Aim 2 will address
these unresolved questions. Blood and plasma are released into the brain parenchyma during neurologic
emergencies, and even without SD, many blood components can contribute to cell injury. The role of excitatory
amino acids in triggering excitotoxicity cascades has been extensively studied. Surprisingly, our novel results
reveal that non-excitatory amino acids induce severe damage to neurons in hypoxic brain tissue. Astroglial VRAC
appears to mediate this injury, and this hypothesis will be tested in Aim 3. The specific aims are: 1) To test the
hypothesis that the activation of neuronal VRAC is the mechanism implicated in SD-induced neuronal swelling
and recovery. 2) To test the hypothesis that the increase in mitochondrial Ca2+ caused by SD is the mechanism
underlying the “commitment point” marking the switch between cell death and recovery from SD. 3) To test the
hypothesis that astroglial VRAC activity mediates neuronal injury by non-excitatory amino acids during hypoxic-
ischemic conditions. Various classic and state-of-the-art technologies such as viral expression, mouse genetics,
intravital imaging, and in vivo FRET-based 2-photon quantitative mitochondrial Ca2+ imaging will be used while
simultaneously monitoring the occurrence of SD with electrophysiology. When applicable, intravital 2-photon
imaging will be followed by ultrastructural analyses with serial section transmission electron microscopy. The
results will bring new insight into mechanisms of acute cellular injury in SD-associated neurologic emergencies.
| Status | Active |
|---|---|
| Effective start/end date | 1/1/26 → 12/31/26 |
Funding
- National Institute of Neurological Disorders and Stroke: $462,933.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.